MEGAN COGHLAN: Open Payments
NPI 1104172931 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 12 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $141 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $141 |
| Madrigal Pharmaceuticals | 1 | $32 |
| KYOWA KIRIN, INC. | 1 | $27 |
| Radius Health, Inc. | 1 | $26 |
| Chiesi USA, Inc. | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $21 |
| Sequel Med Tech, LLC | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $16 |
Products named: REZDIFFRA, CRYSVITA, MYCAPSSA, UNITHROID, TWIIST, RECORLEV, Tirosint, Ozempic.
Industry payments across NY — which companies pay providers there.
